We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 438

DOJ Trial Machine is Staffed Up, Fired Up
  • McDermott Will & Emery
  • USA
  • February 8 2017

The DOJ Antitrust Division scored another trial win this time in a real estate foreclosure bid rigging case. Yesterday’s win follows


The Concept of Full-Function Joint Venture in the EU
  • McDermott Will & Emery
  • European Union
  • August 8 2016

In the European Union (EU), at the inception of a joint venture (JV), parent companies must determine whether the newly created structure presents a


2017 Intellectual Property Law Year In Review
  • McDermott Will & Emery
  • USA
  • January 31 2017

In a year where politics dominated the headlines, intellectual property law still captured a share of the nation's spotlight. 2016 brought big


Massachusetts Court Weighs in on Product Hopping Allegations and Reverse Payment Standing
  • McDermott Will & Emery
  • USA
  • November 11 2016

Addressing a motion to dismiss a bevy of antitrust allegations, the US District Court for the District of Massachusetts held that a class of


General Court of the EU Confirms Fines Imposed on Lundbeck and Generic Drug Manufacturers for Entering into Patent Settlements
  • McDermott Will & Emery
  • European Union
  • September 22 2016

On 8 September 2016, the General Court of the EU (GCEU) handed down five judgments upholding a decision by the Commission of 19 June 2013 imposing


The EU Court of Justice Brings to an End Odile Jacob’s Fight Against Lagardère’s Purchase of Vivendi Universal Publishing
  • McDermott Will & Emery
  • European Union
  • January 29 2016

By its judgment of 28 January 2016 (C-51414 P, Editions Odile Jacob SAS v Commission), the European Court of Justice (Court) upheld the General


‘Sham litigation’ sufficiently plead when generic provides detailed statement and access to ANDA
  • McDermott Will & Emery
  • USA
  • October 30 2015

Explaining the differences between the pleading standards for antitrust and patent misuse defenses, the U.S. District Court for the District of New


International news: focus on energy
  • McDermott Will & Emery
  • Global
  • December 4 2013

Companies with operations in China now face a significantly heightened risk of fines and exposure to private damages claims for cartel behaviour and


No presumption, but inference of irreparable harm permissible under Lanham Act
  • McDermott Will & Emery
  • USA
  • January 29 2015

Addressing interpretation of advertising claims when the packaging or label unambiguously defines a claim term and an inference of irreparable harm


Supreme Court leaves standing decisions on foreign antitrust conduct
  • McDermott Will & Emery
  • USA
  • June 17 2015

On Monday, June 15, the Supreme Court of the United States refused to hear appeals concerning the Foreign Trade Antitrust Improvements Act (FTAIA), 15